Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Equity (2016 - 2025)

Fennec Pharmaceuticals' Return on Equity history spans 15 years, with the latest figure at 0.18% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 15.0% year-over-year to 0.18%, compared with a TTM value of 0.18% through Dec 2025, down 15.0%, and an annual FY2025 reading of 0.66%, up 72.0% over the prior year.
  • Return on Equity for Q4 2025 was 0.18% at Fennec Pharmaceuticals, down from 1.08% in the prior quarter.
  • The five-year high for Return on Equity was 5.23% in Q1 2023, with the low at 202.07% in Q4 2022.
  • Average Return on Equity over 5 years is 10.04%, with a median of 0.03% recorded in 2024.
  • Year-over-year, Return on Equity surged 20349bps in 2023 and then tumbled -596bps in 2024.
  • Tracing FENC's Return on Equity over 5 years: stood at 0.79% in 2021, then tumbled by -25377bps to 202.07% in 2022, then soared by 101bps to 1.42% in 2023, then tumbled by -102bps to 0.03% in 2024, then plummeted by -453bps to 0.18% in 2025.
  • Per Business Quant, the three most recent readings for FENC's Return on Equity are 0.18% (Q4 2025), 1.08% (Q3 2025), and 1.73% (Q2 2025).